Cargando…

Omalizumab as successful treatment option in severe peanut allergy

Detalles Bibliográficos
Autores principales:	Dehlink, E, Bannert, C, Eiwegger, T, Diesner, S, Gruber, S, Szépfalusi, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723556/ http://dx.doi.org/10.1186/2045-7022-3-S3-P20

Ejemplares similares

Severe food allergy in children. Omalizumab as an alternative treatment to elimination diet
por: Pena Peloche, María, et al.
Publicado: (2011)

sIgE to peanut components does not accurately predict the severity of allergy in subjects suspected of peanut allergy
por: Klemans, Rob, et al.
Publicado: (2015)

The impact of maternal‐fetal omalizumab transfer on peanut‐specific responses in an ex vivo placental perfusion model
por: Kothari, Akash, et al.
Publicado: (2022)

A new OIT protocol for severe peanut allergy
por: Kukkonen, AK, et al.
Publicado: (2013)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Adhesion molecules in experimental peanut allergy
por: Bennett, Jami, et al.
Publicado: (2010)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
por: De Schryver, Els, et al.
Publicado: (2015)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Basophil allergen threshold sensitivity, and peanut allergen components in relation to DBPCFC in children with suspected peanut allergy
por: Nilsson, Caroline, et al.
Publicado: (2011)

Peanut allergy in France: preliminary results of the MIRABEL pilot study
por: Nguyen-Grosjean, VM
Publicado: (2013)

Should peanut allergy screening be introduced for all Irish children?
por: Kelleher, Maeve, et al.
Publicado: (2015)

Is allergy to peanuts and nuts a predictive factor for asthma development?
por: Zivanovic, Mirjana, et al.
Publicado: (2015)

Specific IgE to Ara h 2 is the best predictor for peanut allergy in adults and is correlated to clinical severity
por: Klemans, R, et al.
Publicado: (2013)

Improving diagnostic performances of peanut allergy using novel molecular components
por: Richard, Christelle, et al.
Publicado: (2014)

Skin-testing protocol in diagnosing of the IgE-mediated peanut allergy
por: Behroo, Lotfollah, et al.
Publicado: (2015)

Allergen specific responses in cord and adult blood are differentially modulated in the presence of endotoxins
por: Eiwegger, T, et al.
Publicado: (2008)

Efficacy and safety of omalizumab treatment to facilitate successful oral desensitisation in high-risk milk-allergic patients
por: Aguiar, Rita, et al.
Publicado: (2015)

P23 - Boy with severe atopic dermatitis treated with omalizumab
por: Stefanaki, Evangelia, et al.
Publicado: (2014)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Nottingham Eczema Severity Scoring tool can identify children at high risk of food allergy to cow’s milk, egg and peanut
por: Oosthuizen, Lizalet, et al.
Publicado: (2015)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoring
por: Nilsson, Caroline, et al.
Publicado: (2014)

Successful treatment of a patient with adult food allergy and severe asthma using omalizumab
por: Nishie, Miyuki, et al.
Publicado: (2021)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
por: Loureiro, Cláudia Chaves, et al.
Publicado: (2013)

IgE cross-reactivity between the major peanut allergen Ara h 2 and the non-homologous allergens Ara h 1 and Ara h 3
por: Bublin, M, et al.
Publicado: (2013)

Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
por: De Castro, Giovanna, et al.
Publicado: (2013)

Treatment of severe cow’s milk allergy with omalizumab in an adult
por: Klein, Benjamin, et al.
Publicado: (2023)

Usefulness of peanut and hazelnut molecular components for the diagnosis of nut allergy. Our experience in clinical practice
por: Rotiroti, Giuseppina, et al.
Publicado: (2011)

Increasing incidence of peanut allergy doubled in children from Bosnia and Herzegovnia during last decade
por: Bajraktarevic, Adnan, et al.
Publicado: (2011)

Poster 1019: Novel allergy vaccine delivery system for poison ivy urushiol (PI) and peanut (PN)
por: Coifman, Robert, et al.
Publicado: (2014)

Good outcomes of pregnancy in two cases of women treated with omalizumab due to the severe asthma
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2013)

The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)

First results of MIRABEL: a research program to develop tools for risk and cost/benefit analysis of peanut allergy
por: Crépet, A, et al.
Publicado: (2013)

Acrolein: blocking antibody formation: pro tumor, anti-allergy
por: Roth-Walter, Franziska, et al.
Publicado: (2014)

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)

Effect of modification of peanut conglutin on IgE and T cell reactivity in adults with peanut allergy
por: van Hoffen, Els, et al.
Publicado: (2011)

Cord Blood Derived CD4(+)CD25(high) T Cells Become Functional Regulatory T Cells upon Antigen Encounter
por: Mayer, Elisabeth, et al.
Publicado: (2012)

The basophil activation test reflects the severity and the threshold of allergic reactions to peanut – a double-blind-placebo-controlled peanut challenge study
por: Santos, Alexandra, et al.
Publicado: (2015)

P87 - A national multicenter registration of treatment with omalizumab in Danish asthmatic children
por: Spangenberg, Katrine B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_37q9gqqfm4f10ku5m2p0i0bvpb